Insider · CIK 0001542517

Grossman Adam S

CIK 0001542517 Name as filed on the most recent filing

Filed as Grossman Adam S (46)

86 transaction lines · from 46 filings · filed 2013-10-23 to 2026-03-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

86 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-03-16 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 318,360, disposed Open Form 4 filing 0001140361-26-009899
2026-02-17 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 337,680, disposed Open Form 4 filing 0001140361-26-005888
2025-12-15 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 415,590, disposed Open Form 4 filing 0001140361-25-045737
2025-11-19 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 336,000, disposed Open Form 4 filing 0001140361-25-042997
2025-10-24 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 336,000, disposed Open Form 4 filing 0001140361-25-039331
2025-09-15 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 338,730, disposed Open Form 4 filing 0001140361-25-035159
2025-08-15 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 354,480, disposed Open Form 4 filing 0001140361-25-031601
2025-07-15 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 391,860, disposed Open Form 4 filing 0001140361-25-026099
2025-06-16 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 437,010, disposed Open Form 4 filing 0001140361-25-023017
2025-05-15 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 408,450, disposed Open Form 4 filing 0001140361-25-019589
2025-04-15 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 450,660, disposed Open Form 4 filing 0001140361-25-014267
2025-03-19 S, Open-market sale Adma Biologics, Inc.ADMA 2 lines 397,320, disposed Open Form 4 filing 0001140361-25-009928
2024-11-22 S, Open-market sale Adma Biologics, Inc.ADMA 1,033,204, disposed Open Form 4 filing 0001140361-24-047701
2024-08-27 S, Open-market sale Adma Biologics, Inc.ADMA 6,732,900, disposed Open Form 4 filing 0001140361-24-038772
2024-08-26 S, Open-market sale Adma Biologics, Inc.ADMA 4,191,088, disposed Open Form 4 filing 0001140361-24-038772
2024-06-14 S, Open-market sale Adma Biologics, Inc.ADMA 1,071,980, disposed Open Form 4 filing 0001140361-24-030232
2023-08-18 S, Open-market sale Adma Biologics, Inc.ADMA 1,038,350, disposed Open Form 4 filing 0001140361-23-040583
2023-08-16 S, Open-market sale Adma Biologics, Inc.ADMA 13, disposed Open Form 4 filing 0001140361-23-040322
2023-08-15 S, Open-market sale Adma Biologics, Inc.ADMA 2,318,959, disposed Open Form 4 filing 0001140361-23-040322
2022-12-09 P, Open-market purchase Adma Biologics, Inc.ADMA 2 lines 85,700, acquired Open Form 4 filing 0001140361-22-045111
2021-10-25 P, Open-market purchase Adma Biologics, Inc.ADMA 2 lines 350,000, acquired Open Form 4 filing 0001140361-21-035379
2020-09-08 P, Open-market purchase Adma Biologics, Inc.ADMA 8,960, acquired Open Form 4 filing 0001193805-20-001128
2020-08-11 P, Open-market purchase Adma Biologics, Inc.ADMA 2,970, acquired Open Form 4 filing 0001193805-20-001005
2020-08-10 P, Open-market purchase Adma Biologics, Inc.ADMA 3 lines 15,290, acquired Open Form 4 filing 0001193805-20-001005
2020-02-11 P, Open-market purchase Adma Biologics, Inc.ADMA 2 lines 299,999, acquired Open Form 4 filing 0001193805-20-000127
2019-05-17 P, Open-market purchase Adma Biologics, Inc.ADMA 2 lines 120,000, acquired Open Form 4 filing 0001193805-19-000520
2018-06-08 P, Open-market purchase Adma Biologics, Inc.ADMA 2 lines 350,001, acquired Open Form 4 filing 0001193805-18-000820
2017-11-09 P, Open-market purchase Adma Biologics, Inc.ADMA 1,042,750, acquired Open Form 4 filing 0001193805-17-003451
2016-05-03 P, Open-market purchase Adma Biologics, Inc.ADMA 1,300,000, acquired Open Form 4 filing 0001193805-16-003191
2015-12-18 P, Open-market purchase Adma Biologics, Inc.ADMA 54,224, acquired Open Form 4 filing 0001193805-15-002118
2015-12-08 P, Open-market purchase Adma Biologics, Inc.ADMA 2,697, acquired Open Form 4 filing 0001193805-15-002011

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 55
  • Open-market sale 31
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Grossman Adam S, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001542517

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.